Stocktoria
ArriVent BioPharma, Inc. AVBP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-01-26
ArriVent BioPharma, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 748,195 | $17.3M |
| BlackRock Finance, Inc. | 663,265 | $12.3M |
| MILLENNIUM MANAGEMENT LLC | 425,923 | $9.8M |
| D. E. Shaw & Co., Inc. | 368,795 | $8.5M |
| CITADEL ADVISORS LLC | 353,257 | $8.1M |
| TWO SIGMA INVESTMENTS, LP | 48,682 | $1.1M |
| AQR CAPITAL MANAGEMENT LLC | 15,923 | $367,344 |
Source: SEC EDGAR filings · CIK 0001868279 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.